7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Mandibular Diseases D008336 5 associated lipids
Sclerosis D012598 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Macular Degeneration D008268 5 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Acromegaly D000172 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Graves Disease D006111 6 associated lipids
Malnutrition D044342 6 associated lipids
Dyslipidemias D050171 7 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Chronic Disease D002908 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Carcinosarcoma D002296 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Hepatitis C D006526 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Bone Resorption D001862 7 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Arthralgia D018771 8 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Thyroid Diseases D013959 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Osteolysis D010014 8 associated lipids
Obesity, Morbid D009767 8 associated lipids
Periodontal Pocket D010514 9 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Bacteremia D016470 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Osteitis D010000 10 associated lipids
Vision Disorders D014786 10 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Hemophilia A D006467 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Sepsis D018805 11 associated lipids
Aortic Diseases D001018 11 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Song DH et al. Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. 2016 Med. Sci. Monit. pmid:27068490
Kose O et al. Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. 2016 Mar Drugs pmid:27043583
Shah AP et al. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. 2016 PLoS ONE pmid:27019421
Dela Cruz A et al. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27006198
Lis GJ et al. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. 2016 Pol. Arch. Med. Wewn. pmid:27003233
Tsuruda T et al. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. 2016 Hypertension pmid:27001297
Kats A et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. 2016 J. Cell. Mol. Med. pmid:26987561
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Davaine JM et al. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. 2016 Eur J Vasc Endovasc Surg pmid:26652270
Li J et al. Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. 2016 Mol Med Rep pmid:26647856
Cervellati C et al. Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. 2016 Oxid Med Cell Longev pmid:26635910
Zhao N et al. Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. 2016 J. Bone Miner. Res. pmid:26274352
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Wang S et al. Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. 2016 J Ethnopharmacol pmid:27109342
O'Sullivan S et al. Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. 2016 PLoS ONE pmid:27737004
Li M et al. Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. 2016 J. Biol. Chem. pmid:27697839
Shirakawa J and Kulkarni RN Novel factors modulating human β-cell proliferation. 2016 Diabetes Obes Metab pmid:27615134
Xing R et al. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. 2016 Int. J. Mol. Med. pmid:27599586
Yongdi L et al. [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27526445
Qian H et al. FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. 2016 Mol Med Rep pmid:27510616
Røysland R et al. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. 2016 PLoS ONE pmid:27463973
Sun J et al. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. 2016 Int. Immunopharmacol. pmid:27576059
Sasso GR et al. Elevated serum osteoprotegerin levels in women: friend or foe? 2015 Nov-Dec Rev Assoc Med Bras (1992) pmid:26841162
Calasans-Maia MD et al. Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. 2015 Nov-Dec J Appl Oral Sci pmid:26814461
Jianru YI et al. Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. 2015 Nov-Dec J Appl Oral Sci pmid:26814456
SaÄŸlam M et al. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. 2015 Jan-Feb J Appl Oral Sci pmid:25760266
Esteghamati A et al. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. 2015 Aug-Sep Arch Cardiovasc Dis pmid:26184866
Li G et al. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. 2015 Int J Clin Exp Pathol pmid:26884838
Li B et al. Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. 2015 Genet. Mol. Res. pmid:26782591
Goswami S and Sharma-Walia N Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. 2015 BMC Cancer pmid:26608463
Mrozikiewicz-Rakowska B et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. 2015 J. Physiol. Pharmacol. pmid:26579581
Kurz K et al. Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. 2015 Dis. Markers pmid:26576067
Liu W et al. Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. 2015 PLoS ONE pmid:26571489
Schiro A et al. Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. 2015 Sci Rep pmid:26564003
Mizuno M et al. Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. 2015 Sci Rep pmid:26561427
Morisawa T et al. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. 2015 Int Heart J pmid:26549398
Beuselinck B et al. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. 2015 Br. J. Cancer pmid:26528707
Rewiuk K and Grodzicki T Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. 2015 Biomed Res Int pmid:26504794
Pesce Viglietti AI et al. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. 2015 Infect. Immun. pmid:26459511
Nemeth ZK et al. Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. 2015 Sci Rep pmid:26459001
Zhang HL and Jin X Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. 2015 Genet. Mol. Res. pmid:26400332
Ren H et al. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. 2015 Mol Med Rep pmid:26398911
Board-Davies E et al. Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. 2015 Stem Cells Transl Med pmid:26378260
Marley K et al. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. 2015 Exp. Cell Res. pmid:26254896
McCarthy NI et al. Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development. 2015 J. Immunol. pmid:26254339
Grosjean F et al. Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. 2015 PLoS ONE pmid:26247358
Lewis JR et al. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. 2015 PLoS ONE pmid:26222774
Audo R et al. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. 2015 Arthritis Res. Ther. pmid:26220665
Wang J et al. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. 2015 PLoS ONE pmid:26218592
Kao SY and Stankovic KM Transactivation of human osteoprotegerin promoter by GATA-3. 2015 Sci Rep pmid:26216189
Kassem A et al. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. 2015 FASEB J. pmid:26207027
Yang H et al. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. 2015 Int J Clin Exp Pathol pmid:26191212
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Miao X et al. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. 2015 J Orthop Surg Res pmid:26148858
Bartosińska J et al. The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. 2015 Mediators Inflamm. pmid:26146462
Ye XH et al. Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. 2015 Genet. Mol. Res. pmid:26125863
Yu SG et al. Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. 2015 Int J Clin Exp Pathol pmid:26097549
Schmitz F et al. Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. 2015 Cell Metab. pmid:26094892
Kondegowda NG et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. 2015 Cell Metab. pmid:26094891
Telejko B et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. 2015 Ann Agric Environ Med pmid:26094529
Ye M et al. Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. 2015 Mol Med Rep pmid:26459042
Beederman M et al. Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. 2015 Plast. Reconstr. Surg. pmid:26017615
Tanaka Y et al. [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. 2015 Nihon Rinsho Meneki Gakkai Kaishi pmid:26016635
Priyadarshi S et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. 2015 Ann. Hum. Genet. pmid:25998045
Yang Y et al. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. 2015 J. Biol. Chem. pmid:25979341
Ehlken C et al. Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. 2015 PLoS ONE pmid:25978399
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
Kim KR et al. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. 2015 PLoS ONE pmid:25859665
Wu C et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. 2015 Genes Dev. pmid:25846796
Åšwierkot J et al. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25837853
Hassan SH et al. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. 2015 Dis. Markers pmid:25814780
Folestad A et al. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. 2015 Acta Orthop pmid:25811776
Sutton KM et al. The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. 2015 Dev. Comp. Immunol. pmid:25796577
Chung CP et al. A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. 2015 Int J Mol Sci pmid:25679449
HaDuong JH et al. Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. 2015 Int. J. Cancer pmid:25648303
Higgs JT et al. Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. 2015 Mol. Cancer Res. pmid:25636966
Lanza D et al. Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. 2015 PLoS ONE pmid:25635832
Dale MD et al. Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. 2015 Int J Mol Sci pmid:25625518
Ottewell PD et al. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. 2015 Int. J. Cancer pmid:25603921
Son GY et al. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. 2015 J. Dent. Res. pmid:25595364
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Majerczyk M et al. [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. 2015 Postepy Hig Med Dosw (Online) pmid:27259222
Fu Y et al. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. 2015 J. Vet. Sci. pmid:25549213
Lin TH et al. NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. 2015 Tissue Eng Part A pmid:25518013
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Recker EN et al. A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. 2015 J. Periodontol. pmid:25269523
Meijome TE et al. GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. 2015 J. Cell. Physiol. pmid:25205203
Solberg LB et al. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. 2015 Histochem. Cell Biol. pmid:25201349
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754
Nash LA et al. Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. 2015 Mol Nutr Food Res pmid:25488131
Jin Y et al. Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. 2015 Angle Orthod pmid:24810489

Table of Content